Forschungszentrum Jülich GmbH (FZJ)/Institute of Neuroscience and Medicine: INM-5 Nuclear Chemistry | Germany
PUBLICATION PROFILE
Prof Dr. Syed Muhammad Qaim⚡🌍
👨🔬 Summary
Prof. Dr. Syed M. Qaim, a renowned scientist from Jülich, Germany, has over 60 years of experience in radionuclide research. His pioneering work in the development of technologies for SPECT and PET has revolutionized nuclear medicine. He is credited with the production of F-18, Cu-64, and I-124, and is the first to propose the theranostic approach in personalized medicine.
🎓 Education
Prof. Qaim obtained his Ph.D. from Liverpool University and conducted postdoctoral research at Birmingham University and Mainz University. He completed his Habilitation at the University of Cologne, leading to his appointment as a Professor in Nuclear Chemistry in 1997.
💼 Professional Experience
Prof. Qaim worked at the Forschungszentrum Jülich (FZJ), where he led a research group in applied nuclear chemistry. He contributed to nuclear reaction cross sections, the production of medical radionuclides, and the development of radionuclide technologies for medical applications.
🏆 Academic Citations
Prof. Qaim has 424 published articles, with 10,390 citations and an h-index of 52. His work in nuclear data and medical technology has been globally recognized, contributing significantly to the fields of diagnostic imaging and radiotherapy.
🔬 Technical Skills
Prof. Qaim is an expert in nuclear chemistry, radiopharmaceutical production, and cyclotron-based technologies. He specializes in the production of SPECT and PET radionuclides and has pioneered non-standard positron emitters like Cu-64, Y-86, and I-124 for targeted therapy.
🧑🏫 Teaching Experience
Prof. Qaim introduced courses in nuclear data and radionuclide technology at the MSc level and contributed to the creation of the European Master’s Course in Nuclear Applications. He also lectures internationally, including at universities in Germany, Pakistan, Bangladesh, and Hungary.
🔍 Research Interests
Prof. Qaim’s research focuses on medical radionuclides for diagnostics and therapy, particularly for SPECT and PET. His work on non-standard positron emitters such as Cu-64 and Y-86 and his introduction of the theranostic approach have been critical to the development of personalized medicine in nuclear medicine.
📚 Top Notes Publications
An overview of production routes of the non-standard positron emitter 86gY with emphasis on a comparative analysis of the 86Sr(p,n)- and 86Sr(d,2n)-reactions
- Authors: Shuza M. Uddin, Ingo Spahn, M. Shamsuzzoha Basunia, Andrew S. Voyles, Stefan Spellerberg, Mazhar Hussain, Sándor Sudár, Lee A. Bernstein, Bernd Neumaier, Syed M. Qaim
- Journal: Radiochimica Acta
- Year: 2025
- DOI: 10.1515/ract-2024-0375
Cross sections for the formation of Rb84m,g, Rb83, and Rb82m in Sr86(d,x) reactions up to deuteron energies of 49 MeV: Competition between α -particle and multinucleon emission processes
- Authors: M. S. Uddin, S. Sudár, M. S. Basunia, I. Spahn, A. S. Voyles, A. Hermanne, L. A. Bernstein, B. Neumaier, S. M. Qaim
- Journal: Physical Review C
- Year: 2024
- DOI: 10.1103/PhysRevC.110.064608
New directions in nuclear data research for accelerator-based production of medical radionuclides
Resolution of a discrepancy in the γ-ray emission probability from the β decay of Ceg137
- Authors: M. S. Basunia, J. T. Morrell, M. S. Uddin, A. S. Voyles, C. D. Nesaraja, L. A. Bernstein, E. Browne, M. J. Martin, S. M. Qaim
- Journal: Physical Review C
- Year: 2020
- DOI: 10.1103/PhysRevC.101.064619
Theranostic radionuclides: recent advances in production methodologies
- Authors: No specific authors listed
- Journal: Journal of Radioanalytical and Nuclear Chemistry
- Year: 2019
- DOI: 10.1007/s10967-019-06797-y